Journal
BIOMOLECULES
Volume 11, Issue 10, Pages -Publisher
MDPI
DOI: 10.3390/biom11101518
Keywords
hyaluronic acid; natural polymer; inflammatory diseases; drug delivery
Categories
Funding
- European Regional Development Fund (ERDF) [NORTE-01-0145-FEDER-000039]
Ask authors/readers for more resources
Hyaluronic acid is a natural polymer with unique physicochemical and biological properties, widely studied for applications in inflammatory diseases. While exogenous HA may not fully replace the properties of endogenous HA, it can still provide satisfactory pain relief.
Hyaluronic acid (HA) is a natural polymer, produced endogenously by the human body, which has unique physicochemical and biological properties, exhibiting desirable biocompatibility and biodegradability. Therefore, it has been widely studied for possible applications in the area of inflammatory diseases. Although exogenous HA has been described as unable to restore or replace the properties and activities of endogenous HA, it can still provide satisfactory pain relief. This review aims to discuss the advances that have been achieved in the treatment of inflammatory diseases using hyaluronic acid as a key ingredient, essentially focusing on studies carried out between the years 2017 and 2021.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available